A post-hoc analysis of phase II and III trials published in the Journal of Rheumatology revealed that tofacitinib (TOF) was more effective than placebo in …
A recent multicenter, randomized clinical trial published in JAMA Network Open has highlighted the potential of mycophenolate mofetil (MMF) in reducing the risk of severe …
In a recent study published in Clinical Rheumatology, anti-α-1,4-D-polygalacturonic acid (PGA) antibodies have emerged as a promising biomarker for juvenile idiopathic arthritis (JIA), potentially reshaping …
A recent study published in Rheumatic and Musculoskeletal Diseases (RMD) Open has demonstrated the long-term safety and efficacy of ozoralizumab, a novel anti-TNF multivalent variable …
In a significant development for patients with psoriatic arthritis (PsA), the dual interleukin (IL)-17A and IL-17F inhibitor, bimekizumab has shown remarkable effectiveness in reducing disease …
A groundbreaking study published in Cureus identified miRNA-122-5p (miR-122-5p) as a potential biomarker that could revolutionize the diagnosis and treatment of individuals suffering from both …
A long-term follow-up study, EDITA-ON, published in Arthritis Research & Therapy has provided compelling evidence that ambrisentan therapy significantly reduces the risk of developing pulmonary …
A groundbreaking study published in PLOS ONE has revealed a potential bidirectional link between gut microbiota and ankylosing spondylitis (AS), providing new insights into the …
A recent study published in the Journal of Cellular and Molecular Medicine has shed light on the relationship between interleukin-6 (IL-6) and cardiovascular disease (CVD) …